Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
BRAF+
•
Langerhans Cell Histiocytosis
Do you recommend using cell-free BRAFV600E to track response to therapy in pediatric patients with langerhans cell histiocytosis?
Related Questions
How do you approach revaccination after chemotherapy, and what labs (if any) do you use to assess immune reconstitution?
What is your approach to optimizing pre-operative hemoglobin in patients with sickle cell disease?
How would you counsel patients with personal or family histories of autoimmune disease on immune checkpoint inhibitor therapy for Hodgkin lymphoma?
When would you consider use of emapalumab for HLH/MAS ?
When do you consider testing with stroke gene panels in young stroke patients?
How would you counsel a woman with a strong family history of thrombosis about oral contraceptives?
How do you counsel an otherwise healthy patient on how soon they can go back to moderate exercise after a bilateral pulmonary embolism?
What strategies do you find helpful in advanced care planning with patients/families who are very "miracle" centered?
In an adult patient with asymptomatic, isolated neutropenia in whom you suspect a Duffy null phenotype, at what ANC or in what situations would you do a bone marrow to look for other etiologies of neutropenia?
What are your top takeaways from ISTH 2025?
